These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. A mutation screening by DHPLC of PSEN1 and APP genes reveals no significant variation associated with the sporadic late-onset form of Alzheimer's disease. Scacchi R; Gambina G; Moretto G; Corbo RM Neurosci Lett; 2007 May; 418(3):282-5. PubMed ID: 17412506 [TBL] [Abstract][Full Text] [Related]
43. [The AAP and PS1/2 mutations linked to early onset familial Alzheimer's disease increase the extracellular concentration and A beta 1-42 (43)]. Younkin SG Rinsho Shinkeigaku; 1997 Dec; 37(12):1099. PubMed ID: 9577655 [No Abstract] [Full Text] [Related]
45. A novel mutation in the PSEN2 gene (T430M) associated with variable expression in a family with early-onset Alzheimer disease. Ezquerra M; Lleó A; Castellví M; Queralt R; Santacruz P; Pastor P; Molinuevo JL; Blesa R; Oliva R Arch Neurol; 2003 Aug; 60(8):1149-51. PubMed ID: 12925374 [TBL] [Abstract][Full Text] [Related]
52. Neuropsychological profiles of familial Alzheimer's disease associated with mutations in the presenilin 1 and amyloid precursor protein genes. Warrington EK; Agnew SK; Kennedy AM; Rossor MN J Neurol; 2001 Jan; 248(1):45-50. PubMed ID: 11266019 [TBL] [Abstract][Full Text] [Related]
53. [Genetic factors and a polygenic model of Alzheimer's disease]. Rogaev EI Genetika; 1999 Nov; 35(11):1558-71. PubMed ID: 10624576 [TBL] [Abstract][Full Text] [Related]
54. A novel missense mutation in the presenilin-1 gene in a familial Alzheimer's disease pedigree with abundant amyloid angiopathy. Yasuda M; Maeda K; Ikejiri Y; Kawamata T; Kuroda S; Tanaka C Neurosci Lett; 1997 Aug; 232(1):29-32. PubMed ID: 9292884 [TBL] [Abstract][Full Text] [Related]
55. [Alzheimer's disease. Present and future role of genetics]. Roks G Tijdschr Gerontol Geriatr; 2003 Feb; 34(1):13-20. PubMed ID: 12629906 [TBL] [Abstract][Full Text] [Related]
56. Regulatory region variability in the human presenilin-2 (PSEN2) gene: potential contribution to the gene activity and risk for AD. Riazanskaia N; Lukiw WJ; Grigorenko A; Korovaitseva G; Dvoryanchikov G; Moliaka Y; Nicolaou M; Farrer L; Bazan NG; Rogaev E Mol Psychiatry; 2002; 7(8):891-8. PubMed ID: 12232783 [TBL] [Abstract][Full Text] [Related]
57. [Gene diagnosis of Alzheimer's disease and Parkinson's disease]. Tanaka S Rinsho Byori; 2002 Oct; 50(10):965-9. PubMed ID: 12451676 [TBL] [Abstract][Full Text] [Related]
58. The solved and unsolved mysteries of the genetics of early-onset Alzheimer's disease. Rogaeva E Neuromolecular Med; 2002; 2(1):1-10. PubMed ID: 12230301 [TBL] [Abstract][Full Text] [Related]
59. Genetic underpinnings in Alzheimer's disease - a review. Moustafa AA; Hassan M; Hewedi DH; Hewedi I; Garami JK; Al Ashwal H; Zaki N; Seo SY; Cutsuridis V; Angulo SL; Natesh JY; Herzallah MM; Frydecka D; Misiak B; Salama M; Mohamed W; El Haj M; Hornberger M Rev Neurosci; 2018 Jan; 29(1):21-38. PubMed ID: 28949931 [TBL] [Abstract][Full Text] [Related]
60. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. Cataldo AM; Peterhoff CM; Troncoso JC; Gomez-Isla T; Hyman BT; Nixon RA Am J Pathol; 2000 Jul; 157(1):277-86. PubMed ID: 10880397 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]